MAP kinase genes and colon and rectal cancer

Carcinogenesis

Volumn 33, Issue 12, 2012, Pages 2398-2408

  Slattery, Martha L ^a   Lundgreen, Abbie ^a   Wolff, Roger K ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 10; MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 10; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MIXED LINEAGE KINASE 3; NONSTEROID ANTIINFLAMMATORY AGENT; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RECTUM CANCER; SIGNAL TRANSDUCTION; SMOKING;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECTAL NEOPLASMS; SMOKING;

EID: 84870370776     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs305     Document Type: Article

References (26)

1. Imajo, M. et al. (2006) Regulatory mechanisms and functions of MAP kinase signaling pathways. IUBMB Life, 58, 312-317.
2. Qi, M. et al. (2005) MAP kinase pathways. J. Cell. Sci., 118(Pt 16), 3569-3572.
3. Marshall, M.S. (1995) Ras target proteins in eukaryotic cells. FASEB J., 9, 1311-1318.
4. Hirosumi, J. et al. (2002) A central role for JNK in obesity and insulin resistance. Nature, 420, 333-336.
5. Lee, Y.H. et al. (2003) c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem., 278, 2896-2902.
6. Lascorz, J. et al. (2010) Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility. Carcinogenesis, 31, 1612-1619.
7. Barault, L. et al. (2008) Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. Int. J. Cancer, 122, 2255-2259.
8. Slattery, M.L. et al. (1997) Dietary fats and colon cancer: assessment of risk associated with specific fatty acids. Int. J. Cancer, 73, 670-677.
9. Slattery, M.L. et al. (2003) Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr. Cancer, 46, 166-171.
10. Slattery, M.L. et al. (1997) Energy balance and colon cancer-beyond physical activity. Cancer Res., 57, 75-80.
11. Slattery, M.L. et al. (2003) Physical activity and colorectal cancer. Am. J. Epidemiol., 158, 214-224.
12. Edwards, S. et al. (1994) Objective system for interviewer performance evaluation for use in epidemiologic studies. Am. J. Epidemiol., 140, 1020-1028.
13. Samowitz, W.S. et al. (2002) Prognostic significance of p53 mutations in colon cancer at the population level. Int. J. Cancer, 99, 597-602.
14. Slattery, M.L. et al. (2000) Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J. Natl. Cancer Inst., 92, 1831-1836.
15. Samowitz, W.S. et al. (2000) Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol. Biomarkers Prev., 9, 1193-1197.
16. Slattery, M.L. et al. (2007) Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int. J. Cancer, 120, 656-663.
17. Slattery, M.L. et al. (2009) A comparison of colon and rectal somatic DNA alterations. Dis. Colon Rectum, 52, 1304-1311.
18. Nyholt, D.R. (2004) A simple correction for multiple testing for singlenucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet., 74, 765-769.
19. Li, J. et al. (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb)., 95, 221-227.
20. Rodríguez-Berriguete, G. et al. (2012) MAP kinases and prostate cancer. J. Signal Transduct., 2012, 169170.
21. Dhillon, A.S. et al. (2007) MAP kinase signalling pathways in cancer. Oncogene, 26, 3279-3290.
22. Hardwick, J.C. et al. (2001) NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene, 20, 819-827.
23. Licato, L.L. et al. (1998) Analysis of signaling protein kinases in human colon or colorectal carcinomas. Dig. Dis. Sci., 43, 1454-1464.
24. Keyse, S.M. (2000) Protein phosphatases and the regulation of mitogenactivated protein kinase signalling. Curr. Opin. Cell Biol., 12, 186-192.
25. Heasley, L.E. et al. (2006) JNK regulation of oncogenesis. Mol. Cells, 21, 167-173.
26. Turjanski, A.G. et al. (2007) MAP kinases and the control of nuclear events. Oncogene, 26, 3240-3253.